Polymer-free paclitaxel-coated zilver PTX stentsevaluation of pharmacokinetics and comparative safety in porcine arteries

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 5, 2011, Pages 603-610

  Dake, Michael D ^a   Van Alstine, William G ^b   Zhou, Qing ^c   Ragheb, Anthony O ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Med Institute Inc Lafayette   (United States)

Author keywords

Cardiovascular and Interventional Radiological Society of Europe; CIRSE; LCMS; liquid chromatographymass spectrometry; SFA; superficial femoral artery; TCT; Transcatheter Cardiovascular Therapeutics

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

ANIMAL EXPERIMENT; ARTERY; ARTICLE; AUTOPSY; BARE METAL STENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEALING; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SWINE;

ALLOYS; ANIMALS; ARTERIES; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; FEMALE; MALE; MATERIALS TESTING; MODELS, ANIMAL; PACLITAXEL; PROSTHESIS DESIGN; RISK ASSESSMENT; SUS SCROFA; WOUND HEALING;

EID: 79955476229     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.12.027     Document Type: Article

References (35)

1. E. Minar, B. Pokrajac, and T. Maca Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study Circulation 102 2000 2694 2699
2. J.A. Dormandy, R.B. Rutherford Management of peripheral arterial disease (PAD) TASC Working Group TransAtlantic Inter-Society Consensus (TASC) J Vasc Surg 31 2000 S1 S296
3. M. Schillinger, S. Sabeti, and C. Loewe Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888 (Pubitemid 43872689)
4. M. Schillinger, S. Sabeti, and P. Dick Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting Circulation 115 2007 2745 2749 (Pubitemid 46842791)
5. M. Bosiers, G. Torsello, and H.M. Gissler Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study J Endovasc Ther 16 2009 261 269
6. H. Krankenberg, M. Schluter, and H.J. Steinkamp Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292 (Pubitemid 47196564)
7. T. Zeller, C. Tiefenbacher, and H.J. Steinkamp Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT) J Endovasc Ther 15 2008 390 398
8. D.I. Axel, W. Kunert, and C. Goggelmann Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645 (Pubitemid 27329445)
9. S.J. Sollott, L. Cheng, and R.R. Pauly Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat J Clin Invest 95 1995 1869 1876
10. C. Herdeg, M. Oberhoff, and A. Baumbach Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J Am Coll Cardiol 35 2000 1969 1976 (Pubitemid 30342882)
11. B. Scheller, U. Speck, and B. Romeike Contrast media as carriers for local drug delivery: successful inhibition of neointimal proliferation in the porcine coronary stent model Eur Heart J 24 2003 1462 1467 (Pubitemid 36961837)
12. B. Scheller, U. Speck, A. Schmitt, M. Bohm, and G. Nickenig Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation J Am Coll Cardiol 42 2003 1415 1420 (Pubitemid 37267283)
13. W.J. van der Giessen, A.M. Lincoff, and R.S. Schwartz Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697 (Pubitemid 26320276)
14. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705 (Pubitemid 38222887)
15. A. Gershlick, I. De Scheerder, and B. Chevalier Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 109 2004 487 493 (Pubitemid 38168511)
16. M.K. Hong, G.S. Mintz, and C.W. Lee Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) Circulation 107 2003 517 520 (Pubitemid 36176797)
17. E. Grube, S. Silber, and K.E. Hauptmann TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42 (Pubitemid 36070930)
18. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699 (Pubitemid 351240748)
19. M. Werk, S. Langner, and B. Reinkensmeier Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
20. Guide for the Care and Use of Laboratory Animals 1996 National Research Council, National Academy Press Washington, DC
21. EN ISO 10993-2: Biological evaluation of medical devices Part 2. Animal Welfare Requirements 1992 International Organization for Standardization
22. Good Laboratory Practice for Nonclinical Laboratory Studies, 21 CFR Part 58 2004
23. R.S. Schwartz, E.R. Edelman, and A. Carter Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group Circulation 106 2002 1867 1873
24. A.J. Carter, J.R. Laird, A. Farb, W. Kufs, D.C. Wortham, and R. Virmani Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model J Am Coll Cardiol 24 1994 1398 1405 (Pubitemid 24331884)
25. R.S. Schwartz, K.C. Huber, and J.G. Murphy Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model J Am Coll Cardiol 19 1992 267 274
26. R. Kornowski, M.K. Hong, F.O. Tio, O. Bramwell, H. Wu, and M.B. Leon In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia J Am Coll Cardiol 31 1998 224 230 (Pubitemid 28064746)
27. A. Finkelstein, D. McClean, and S. Kar Local drug delivery via a coronary stent with programmable release pharmacokinetics Circulation 107 2003 777 784 (Pubitemid 36222609)
28. C.J. Creel, M.A. Lovich, and E.R. Edelman Arterial paclitaxel distribution and deposition Circ Res 86 2000 879 884 (Pubitemid 30246985)
29. A.D. Levin, N. Vukmirovic, C.W. Hwang, and E.R. Edelman Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel Proc Natl Acad Sci U S A 101 2004 9463 9467 (Pubitemid 38812897)
30. P.H. Wiernik, E.L. Schwartz, J.J. Strauman, J.P. Dutcher, R.B. Lipton, and E. Paietta Phase I clinical and pharmacokinetic study of taxol Cancer Res 47 1987 2486 2493 (Pubitemid 17099218)
31. B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Bohm, and G. Nickenig Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814 (Pubitemid 39096008)
32. U. Speck, B. Scheller, and C. Abramjuk Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries Radiology 240 2006 411 418 (Pubitemid 44098636)
33. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124 (Pubitemid 44749319)
34. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
35. N. Tada, R. Virmani, and G. Grant Polymer-free Biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting Cypher stent in a porcine model Circ Cardiovasc Interv 3 2010 174 183